Miravant Medical Technologies is a pharmaceutical research and development company which specializes in photodynamic therapy or PDT, a treatment modality based on drugs that respond to light.
It develops light activated drugs and associated devices for photodynamic therapy through its novel version of PDT technology with the trademark PhotoPointâ.
These drugs induce a photochemical reaction in the presence of oxygen that can be used to locally destroy diseased cells and abnormal blood vessels. Their drugs and devices are in various stages of development and require regulatory approval prior to sales, marketing or clinical use.
Company profile
Ticker
MRVT
Exchange
CEO
David E. Mai
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
PDT Inc
SEC CIK
Corporate docs
IRS number
770222872
Latest filings (excl ownership)
15-12G
Securities registration termination
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
POS AM
Prospectus update (post-effective amendment)
31 Mar 06
Latest ownership filings
11-K
Annual report of employee stock purchases
29 Jun 05
11-K
Annual report of employee stock purchases
28 Jun 04
11-K
Annual report of employee stock purchases
30 Jun 03
11-K
Annual report of employee stock purchases
27 Jun 02
11-K
Annual report of employee stock purchases
28 Jun 01
11-K
Annual report of employee stock purchases
26 Jun 00
11-K
Annual report of employee stock purchases
14 Jul 99
NT 11-K
Notice of inability to timely file Form 11-K
29 Jun 99
11-K
Annual report of employee stock purchases
30 Jun 98